1 article

Pharmaceutical company bullying: The case of Novartis

Catherine Tomlinson

Sept. 14, 2011, 12:24 p.m.

Novartis is trying to extend its patent on a cancer drug in India. It is this kind of behaviour that gives pharmaceutical companies a bad name and emboldens anti-pharma quackery.

Tags: , , | 0 comments

Copyright © 2011 Treatment Action Campaign and Community Media Trust.
The aim of Quackdown is to inform consumers and patients about untested and implausible health-care claims.
Quackdown is implemented using free and open source software.
Unless otherwise noted, all material on the site is published under the Creative Commons Attribution 3.0 Unported license.
The site is implemented using the Django web framework and the django-pubman content management system.
The source for Quackdown can be downloaded from Github.